The results are an outcome of the company's focus on sustainable and profitable growth and reflects all the hard work and focus teams have put in over the years
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
Revolutionary technology will further boost OneSource’s scientific services offerings
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
Strong topline growth driven by solid performance across key brands.
The acquisition will further strengthen Barentz’ position in India creating a leading life science distribution platform
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
This strategic move aims to make Cupid's high-quality products more accessible to consumers nationwide
EBITDA grew by 31% YoY with EBITDA margin of 11%, a YoY improvement of over 170bps vs. Q1FY24
Subscribe To Our Newsletter & Stay Updated
